Effect of methylprednisolone in epinephrine-thyroxine induced arteriosclerosis.
D000818:Animals; D001013:Aorta, Thoracic / Q000201:enzymology / Q000473:pathology; D001161:Arteriosclerosis / Q000139:chemically induced* / Q000473:pathology; D003094:Collagen / Q000096:biosynthesis; D004837:Epinephrine / Q000008:administration & dosage; D006909:Hydroxyproline / Q000032:analysis; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology*; D011393:Procollagen-Proline Dioxygenase / Q000032:analysis / Q000037:antagonists & inhibitors; D011817:Rabbits; D013974:Thyroxine / Q000008:administration & dosage
D003094:Collagen; D011393:Procollagen-Proline Dioxygenase; D013974:Thyroxine; D006909:Hydroxyproline; D008775:Methylprednisolone; D004837:Epinephrine